Stockreport

Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Vertex enjoys a dominant position in the cystic fibrosis (CF) market. Vertex's CF sales continue to grow, driven by its triple therapy, Trikafta (marketed as Kaftrio in [Read more]